CELEGATO, MARTA

CELEGATO, MARTA  

Dipartimento di Medicina Molecolare - DMM  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.073 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 2020 Celegato M.Messa L.Mercorelli B.Bertagnin C.Palu G.Loregian A. + CANCER LETTERS - -
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 2018 Messa, LorenzoCelegato, MartaBertagnin, ChiaraMercorelli, BeatriceNannetti, GiulioPalù, GiorgioLoregian, Arianna SCIENTIFIC REPORTS - -
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 2023 Bertagnin C.Celegato M.Sturlese M.Mercorelli B.Moro S.Loregian A. + CANCER LETTERS - -
ALIX-mediated rescue of feline immunodeficiency virus budding differs from that observed with human immunodeficiency virus 2020 Del Vecchio C.Celestino M.Celegato M.Palu G.Parolin C.Calistri A. + JOURNAL OF VIROLOGY - -
Caratterizzazione della regione carbossi-terminale della proteina strutturale GAG del virus dell'immunodeficienza felina (FIV) 2009 Celegato, Marta - - -
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 2017 NANNETTI, GIULIOMESSA, LORENZOCELEGATO, MARTAPAGNI, SILVANABASSO, MONICAParisi, Saverio G.PALU', GIORGIOLOREGIAN, ARIANNA JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS - -
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 2022 Mercorelli, BeatriceDesantis, JennyCelegato, MartaBazzacco, AlessandroLoregian, Arianna + ANTIVIRAL RESEARCH - -
Dissection of the carboxy-terminal region of FIV-Gag: role in virus like particle production 2008 CELEGATO, MARTADEL VECCHIO, CLAUDIASALATA, CRISTIANOCELESTINO, MICHELECALISTRI, ARIANNAPALU', GIORGIOPAROLIN, MARIA CRISTINA - - Abstract book
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 2021 Desantis J.Mercorelli B.Celegato M.Bazzacco A.Loregian A. + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein 2018 Mercorelli, BeatriceCelegato, MartaPalù, GiorgioGribaudo, GiorgioLoregian, Arianna + ANTIVIRAL RESEARCH - -
Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress 2009 CALISTRI, ARIANNADEL VECCHIO, CLAUDIASALATA, CRISTIANOCELESTINO, MICHELECELEGATO, MARTAPALU', GIORGIOPAROLIN, MARIA CRISTINA + JOURNAL OF CELLULAR PHYSIOLOGY - -
SFV/HIV chimera as a new approach for HIV-1 antigen expression and delivery 2006 DEL VECCHIO, CLAUDIACELEGATO, MARTABIASOLO, MARIA-ANGELACALISTRI, ARIANNAPALU', GIORGIOPAROLIN, MARIA CRISTINA + - - -
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo 2023 Celegato M.Sturlese M.Trevisan M.Favaro A.Moro S.Loregian A.Mercorelli B. + MBIO - -
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 2022 Celegato M.Messa L.Bertagnin C.Mercorelli B.Loregian A. CANCERS - -
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs 2021 Mercorelli B.Celegato M.Gribaudo G.Loregian A. + ANTIVIRAL RESEARCH - -
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication 2020 Beatrice MercorelliMarta CelegatoGiorgio PalùGiorgio GribaudoArianna Loregian + ANTIMICROBIAL AGENTS AND CHEMOTHERAPY - -
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 2021 Messa L.Celegato M.Bertagnin C.Mercorelli B.Alvisi G.Palu G.Loregian A. + CANCERS - -